Inflammation-Based Prognostic Score Predicts Survival in Patients with Advanced Gastric Cancer Receiving Biweekly Docetaxel and S-1 Combination Chemotherapy

Publisher： Karger

E-ISSN： 1423-0232|83|4|183-191

ISSN： 0030-2414

Source： Oncology, Vol.83, Iss.4, 2012-08, pp. : 183-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Biweekly Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 77, Iss. 1, 2009-06 ,pp. : 49-52

Karger

Access to resources Recommend Favorite

Evaluation of an Inflammation-Based Prognostic Score in Patients with Inoperable Pancreatic Cancer

By  

Pancreatology, Vol. 6, Iss. 5, 2006-10 ,pp. : 450-453

Karger

Access to resources Recommend Favorite

Comparison of Two Inflammation-Based Prognostic Scores in Patients with Unresectable Advanced Gastric Cancer

By  

Oncology, Vol. 83, Iss. 5, 2012-09 ,pp. : 292-299

Karger

Access to resources Recommend Favorite

The preoperative globulin‐to‐albumin ratio, a novel inflammation‐based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 116, Iss. 8, 2017-12 ,pp. : 1166-1175

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inflammation‐Related Genetic Variations and Survival in Patients With Advanced Non–Small Cell Lung Cancer Receiving First‐Line Chemotherapy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 3, 2014-09 ,pp. : 360-369

John Wiley & Sons Inc

Access to resources Recommend Favorite